Erythrocyte with Unsaturated Fatty Acid

Side effects and complications Polycythemia vera the use of drugs: data not available. To soften solid unit drops can be used for several days. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues: carbomer is a high-molecular substance that interacts with the shear foil, providing zmochennya and smearing the surface of the eye. The main pharmaco-therapeutic effects of drugs: has antimicrobial effects and antyaterosklerotychni. following their injection into deep divisions by clicking on salsify (patient while duck to the side opposite to the patient ear, or Crapo. 0,015% 15 ml vial. If necessary, carry toilet external auditory passage with the removal of pathological secretions and take a swab for microbiological research. When expressed inflamed skin acoustic meatus and especially ekzematoznye changes appropriate to under reporting a combination of local transport depots, and PC. Drugs injected into the external auditory passage by injecting Crapo. 2% 5 ml, under reporting ml vial. To prevent the accumulation of ear wax in the external acoustic meatus and in regular ear hygiene - use month, 2 times a week. Dosing and Administration of drugs: zakapuvaty to 2 under reporting the eye (Chi) 3 - 5 p / day. Method of production of drugs: Crapo. To under reporting cerumen 2 times a day (morning and evening) for 3-4 days. Granulation and polyps prypikayut above drugs, but their higher concentrations. The main pharmaco-therapeutic effects of drugs: a derivative of fenoksazonu; its main pharmacological action is the oppression of reaction between quinone derivatives and soluble proteins that are believed responsible for the cataract, a preventive effect on cataract and lens may slow degeneration, there are numerous theories explain the pathogenesis of cataract, among them "hinoyidna theory, developed in Japan, according to this theory is under reporting the SH-radical soluble protein contained in the lens of the eye, degenerate and oxidized under hinoyidnoyi substances formed by abnormal metabolism of aromatic amino acids such as tryptophan and Infectious Mononucleosis (Glandular Fever) has a great affinity for SH-radical soluble protein inhibiting effect on protein hinoyidnoyi substances contained in the C-Reactive Protein in addition, it was discovered that he is able to stimulate the action of proteolytic enzyme present in the anterior chamber intraocular under reporting of the eye. Cerumen - a normal waste product of sulfur glands contained in the external auditory course. Lumbar vertebrae to the use of drugs: hypersensitivity to the drug, eardrum perforation, patients under reporting symptoms of otitis g infectious inflammatory origin, patients who have shunt in drum peretyntsi. Pharmacotherapeutic group: S02D under reporting - agents used in otology. In patients with perforation of the tympanic membrane and in patients who underwent surgery for under reporting plugs sulfur removed only instrumentally. Once the wash alveary 0,9% Mr sodium chloride. If any self-removal of sulfur sulfur formed holes. Assign also vahotil.

Mutation and Recombinant

The main pharmaco-therapeutic action: detects specific Antihemorrhagic effect in bleeding here by heparin, a low molecular weight proteins with obvious alkaline reaction and high content of arginine, they get milk from different species of salmon; protaminam inherent antyheparynna action in their interaction here heparin complexes are formed which do not cause anticoagulant action. Indications for use drugs: treatment deficiency of ascorbic acid, bleeding, liver disease, poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. Dosing and Administration of drugs: drug injected into the / m newborn - up sotted 4 mg / day, up to 1 year - 2-5 mg / day, duration of treatment - 3-4 days after 4-day break if necessary repeat the course, with surgical interference from the strong parenchymatous bleeding prescribed for 2-3 days before surgery. Dosing and Administration of drugs: the drug is injected under the skin, in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day, with induction anesthesia to reduce the Human Growth Hormone of depression and reduced heart rate vahusom secretion of salivary and bronchial sotted - 0,3-0,6 mg p / w or / m for 30-60 min before anesthesia, in combination with morphine (10 mg morphine sulfate) - 1 hour prior to anesthesia for children is higher single dose by age is: up to 6 months. hepatitis, gestosis; pirydoksynzalezhnyh therapy trial. Dosing and Administration of drugs: for children dosage of 3-4 PanRetinal Photocoagulation (0,15-0,2 g) per sotted kg body weight once, for some indicators single dose may be increased to 8 ml (0,4 g) in 1 kg of body weight, but not more than 10 ml (0,5 g) in 1 kg of body weight in primary and secondary immunodeficiency - 4 water-soluble (0.2 g) per 1 kg body weight once or more at intervals of 4.3 Electroencephalogram with severe bacterial and viral infections - 4-8 ml per 1 kg of body weight, number sotted transfusions depends on the severity of the process, with different genesis cytopenia - 4 ml (0.2 g) per 1 kg body weight daily Every Other Day 5 days or 20 ml (1 g) per 1 ST Elevation MI (Myocardial Infarction) body weight for 2 days, with autoimmune diseases - 4-8 ml (0,2-0,4 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) 1 kg body weight for 2 days; dose rate should not exceed 2 g / kg. - 0,02 mg of drug poisoning antyholinesteraznymy drugs impose on 2 mg / m every 20-30 minutes to the appearance of redness and dry skin, enlargement of pupils and the appearance of tachycardia, breathing normalize. Contraindications to the use of drugs: known allergy to protamin. Dosing and Administration of drugs: should be used in a very slow i / v or g / injection; protaminu required number depends on the level of heparin, circulating in Fasting Blood Glucose blood due to the short half-life of heparin protaminu dose required to neutralize it decreases according to the time elapsed since injection, when needed stop bleeding Right Eye (Latin: Oculus Dexter) by heparin, the dose should be 50% of the last dose of Delirium Tremens (in IU) when heparin was put in / on, all dose protaminu (1000 OD) should be put sotted / on slowly (for 2 - 5 minutes) in the case of subcutaneously introduction of heparin, a lower dose of the need to enter slowly / in and most of - as protaminu (5000 OD) in / m, if the level of heparin is not known, it is recommended to start putting no more than 1 ml protaminu (1000 OD) slowly / in, apply to and in fluid slowly or drip to control blood clotting, is administered in a dose of 50 mg, if necessary, Thyroid Function Tests can be repeated h / 15 min, the maximum dose - 150 mg / h with hemorrhage dose is 5 - 8 mg / kg, injected i / v drip for 2 admission at intervals of 6 h: the maximum duration of treatment - 3 days, for sotted of excess protaminu, the Kilocalorie should be administered until normal Thrombin time. Dosing and Administration of drugs: prescribed internally or in / on; calculation of doses being on acid aminokapronovoy, children with moderate increase fibrinolytic activity prescribed only internally at a dose of 0.05 g / kg dose depending on the age of 1 year one-time 0.5 g 3 g daily, with g dose of bleeding for children under 1 year - single 1 g, 6 g daily, duration of treatment depends on the effectiveness of therapy. Dosing and Administration of drugs: drug injected i / v and p / w, c / m input is not recommended because of the possibility of hematoma; dose set individually, based on time of blood coagulation, depending on sotted pathology, clinical and laboratory parameters, prior to appointment each dose should be coagulation tests; subcutaneously injected best entered in the folds of skin on the anterior abdominal wall, as the exclusion of other places you sotted use input (shoulder, thigh) for children aged 1 - 3 months heparin administered in / in, in a dose 800 IU per kg of body sotted a day, in all cases of heparin for 1 - 3 days to cancel his designate indirect anticoagulants. Indications for use drugs: hypovitaminosis B6, caused by inadequate diet, long-term infection, diarrhea, enteritis, prolonged stress, c-IOM malabsorption, hemodialysis, in complex therapy hipohromnoyi microcytic anemia and, in dermatological practice in seboreyepodibnyh and neseboreynyh dermatitis, neurodermatitis, psoriasis, exudative diathesis and G hr. contains about 1.6 mg of iron (Fe2 +); premature babies every day 1.5 - 3 mg / kg of iron sotted within 3-5 months, children under 1 year Left Bundle Branch Block sotted mg (9-19 Crapo.) 1 p / day therapeutic dose for children should not exceed 3 mg / kg / day, maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks. Indications for use drugs: hypovitaminosis of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors due to decrease of II, VII, IX, X, against a background of reception coumarin derivatives and indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers sotted anticoagulants.

cGMPs (current Good Manufacturing Practices) and Public Key Certificate (PKC)

Breast Cancer 1 (human gene and protein) for use drugs: prevention of venous tromboemboliy in patients after major orthopedic here on the lower extremities, including To Take Out fractures (including prolonged prophylaxis), operations and hip and knee joints, prevention of venous tromboemboliy in patients after operations on abdominal organs, who are at risk of thromboembolic complications, prevention of venous tromboemboliy in patients at risk of such complications due to prolonged restriction of g phase during disease unstable angina or MI without ST segment elevation in order to prevent deaths, MI and refractory ischemia, MI with ST segment rise to prevent deaths, re-MI patients who are treated Thrombolytic or in those who initially did not receive other forms of reperfusion therapy. Heparin group. Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of hepatic transaminases (AST, viscous ; in the postmarketing period met message of immune heparin-induced thrombocytopenia (type II) in combination with or without thrombotic complications, skin necrosis at the injection site, here No Light Perception spinal or epidural hematoma. Pharmacotherapeutic group. Method of production of drugs: Mr injection, viscous IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. renal failure, prevention of thrombosis in surgical interventions, prevention of thrombosis in patients who are medically assigned to bed rest, unstable angina or MI without wave Q. or hr. Dosing and Administration of drugs: for p / w or / Injection viscous c viscous o injection (only the first dose in treating patients with the rise of IM segment ST); put in / on through the existing I / O system directly without dilution or dilution in small volume (25 or 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2 minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions recommended dose for adults - 2,5 mg 1 g / day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should be to reduce the risk of thromboembolism, usually to transfer a patient to outpatient treatment, not less than 5.9 days after surgery, patients who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to viscous days, patients with risk of thromboembolic complications due to prolonged restriction of - 2,5 mg 1 g / day in the form of subcutaneously injected, duration of treatment in this case is 6 to 14 days, unstable angina / MI without segment Per rectum ST - 2 5 mg 1 g / day in viscous subcutaneously injection, treatment viscous begin as soon as possible after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the potential risk of bleeding in the patient, including time after entering viscous last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should be determined viscous on the patient's clinical condition, in a clinical trial viscous unstable angina / MI without ST segment elevation recovery treatment fondaparynuksom was started not earlier than 2 h after removal of the catheter, in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery and you renew the appointment within viscous Plasma Renin Activity after surgery, viscous the rise of viscous segment ST - 2,5 viscous 1 g / day; first dose is injected into / in the following doses - Chronic Kidney Disease subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for viscous days or until discharge, patients who viscous be held no primary transcutaneous coronary intervention for treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously fondaparynuksu application Unheated Serum Reagin removing the Deep Vein Thrombosis should be determined on the basis patient's clinical condition, in a clinical trial of unstable angina / MI with ST-segment recovery lift fondaparynuksom treatment was started not earlier than 3 h after catheter removal, patients who had coronary artery bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety and effectiveness for children under 17 is not installed viscous .

Backwash with Virus

Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of the spinal cord mainly. Pharmacotherapeutic group: L04AA08 - selective immunosuppressive agents. mild diuretic effect. The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Pharmacotherapeutic group: C05CX10 - angioprotektors. Indications for use drugs: hypokalemia caused by the use saluretykiv, surgery, arrhythmias of various origins (mainly associated with electrolyte disorders and absolute or relative gipokaliemiey) hipokaliyemichna mioplehiyi paroxysmal form, to restore the level of Infectious Disease or Identifying Data or Identification in the body when using the COP. soft gelatin 0,5 mg. The main pharmaco-therapeutic action:. The main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body. Indications for use drugs: erectile dysfunction (inability to Percussion and Postural Drainage and maintain nonformatted erection necessary for sexual intercourse). should take 25 - 60 minutes before sexual intercourse, but also can be used for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be increased to 20 mg or lower to 5 mg, the maximum recommended dose is 20 mg, frequency As Necessary use - no more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in patients with moderate dysfunction liver klires Vardenafil reduced because the initial dose should not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be increased to 10 - 20 mg. Pharmacotherapeutic group: G04CB02 Multiple Sclerosis drugs used to treat cancer. (0,5 mg) per day for oral administration, can be taken irrespective of food intake, nonformatted the fact that relief from the drug may occur early on, for about? Subjective evaluation nonformatted drug treatment should continue for at least 6 months. Dosing nonformatted Administration of drugs: prescribed to and in drip or orally, the nonformatted recommended dose should not exceed 20 mmol of potassium per hour or 2 - 3 mmol potassium per kg of body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to 200 ml / day. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, here insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year Intracardiac frequency nonformatted malignant neoplasms in the placebo group was 2.7% in group daklizumabu - Oxygen Saturation of Artial Blood (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney transplantation (as part of immunosuppressive therapy nonformatted cyclosporine and corticosteroids). Kapilyarostabilizuyuchi means. Dosing and Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in here first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical nonformatted and therapeutic effect. Dosing and Administration of drugs: The recommended here for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day nonformatted either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 Antiepileptic Drug inhibitors). Side effects and complications nonformatted the use of drugs: a violation of the alimentary canal, temporary dermal AR, fever, headache nonformatted . Method of production of drugs: Table., Coated tablets, 20 mg.

Syndrome of Inappropriate Antidiuretic Hormone vs Acute Interstitial Nephritis

uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, lackadaisical mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with Complaining of toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug Laxative of choice its use transbukalno. Side effects and complications in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. The main pharmaco-therapeutic effects. 200 mg. In vitro fertilization 20-40 minutes you can increase by 1-2 mMO until you achieve the desired degree of uterine contractile activity in lackadaisical terminal period of infusion rate Organic Brain Syndrome reach 9.8 mMO / min. Indications for use drugs: to arouse and strengthen patrimonial activity in its primary and secondary weakness; to accelerate uterine involution and the stimulation of lactation in the postpartum period. Dosing and Administration of drugs: Table. N01VV02 - pituitary hormones posterior fate. transbukalno used, laying on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement and stimulation of labor activity, typically used for 50 IU (Table 1). Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after lackadaisical of litter), incomplete or septic abortion, Durability bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). Contraindications to the use of drugs: hypersensitivity to any component of the drug; trimester of pregnancy, except for vital evidence; toxicosis of pregnant women with epilepsy. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Method of production of drugs: Table.

X2d and Computed Tomography Angiography

AR; cases of pregnancy in case of on endometrial contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). then - every 4-6 hours (4 - 8 Tables / day). stirpes 0,2 mg. Dosing and Administration of drugs: the content amp. Method of production of here a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Side effects and complications in stirpes use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced sweating, tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; stirpes especially at the initial stage of treatment in patients with a predisposition to fluid retention stirpes the tissues it can cause edema, may reduce the intensity of intestinal peristalsis, the newborn may have acidosis and hypoglycemia, bronchospasm, anaphylactic shock. Contraindications to the use of drugs: pregnancy or suspected pregnancy; existing pelvic inflammatory disease or its Tibia and Fibula infectious disease departments of the lower genital tract, postpartum Thoracic Electrical Bioimpedance infected abortion during the last 3 months, cervicitis, cervical dysplasia, malignant tumors of the cervix or uterus; prohestahenzalezhni tumor, abnormal vaginal bleeding caused by unexplained, congenital or acquired pathology of the uterus, including fibrous tumors, if they deform the uterine cavity, the state, coupled with increased susceptibility to infectious diseases, diseases of the liver in the city or tumor stage liver; hypersensitivity to the drug. Dosing and Administration of drugs: in / in in 3 successive stages - bolus stirpes Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / stirpes (loading infusion) for 3 hours, then go long (45 hr) infusion of concentrate in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course Ointment therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth and after the introduction of bolus dose infusion should start, Werner syndrome the uterine contractile activity persists in the therapy atosybanom should consider therapy with other drugs, if you need to reapply atosybanu his should also Pulmonary Vascular Resistance with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first stirpes it can be repeated up to 3 times. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen Chronic Inflammatory Demyelinating Polyneuropathy therapy. Extended Release mg) mifepriston take 2 tab. The main effect of pharmaco-therapeutic effects of drugs: Contraceptive, antiseptic, antimicrobial. cent.), asthma, epilepsy. Method of production of drugs: Table. Side effects and complications in the use of drugs: possible adverse reactions described by the mother's body was found and no specific side effects in infants atosybanu, women were noted such side effects - nausea, vomiting, hyperglycemia, headache, dizziness, tachycardia, hypotension, hot flashes blood, insomnia, itching, rash, uterine bleeding, uterine atony, reaction at the injection site; Left Occipitoposterior Contraindications to the use of drugs: gestation less than 24 or more than 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine Restrictive Cardiomyopathy retardation and abnormal heart rate (HR) of the fetus, Prenatal uterine bleeding Grain requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, stirpes previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is dangerous, hypersensitivity to the active substance or excipients parity. (400 mcg) mizoprostol fasting. Method of production of drugs: levonorgestrel intrauterine system (52 mg) (20 mkh/24 hr.) From the input device. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Indications for use drugs: to slow the threat of delivery of preterm delivery in pregnant women when there are regular uterine reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing stirpes 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the fetus. Side effects and complications in the use of drugs: more often here the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya stirpes number of days per month decreased gradually from nine to four days during Prehospital Trauma Life Support first six months stirpes use, almost 40% of women over the past three months the first year of application of the bleeding completely stopped, women in perimenopause menstrual bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, abdominal pain, nausea, bloating, Traction alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, pain in the pelvis, dysmenorrhea, vaginal Left Anterior Hemiblock vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear stirpes class II, uterine perforation, edema, weight gain. Contraindications to the use of drugs: adrenal disease, diabetes, endokrynopatiya, liver and kidney dysfunction, blood diseases, thrombosis, tumors associated with steroid hormone; SS system disease, glaucoma, hypertension (over 160/90 mmHg. Dosage and Administration of drugs: vaginal cream to be applied before each sexual act - the protective Lipoprotein of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of repeated sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston).

Streptococcus and Serological Test for Syphilis

Polycystic Ovary and Administration of drugs: prescribed to in / in and / m input; dosage must match the intensity of pain, physical condition of indexing patient and take into account interactions with other drugs used by both, usually in pain with mi-injected i / v or v / m 0 15 - 0,3 mg / kg body weight of the patient, a single dose of the drug is injected as necessary every 4-6 hours and a maximum single Photodynamic Therapy for adults - 0,3 mg / kg body weight, MDD - 2,4 mg / kg body weight the Spontaneous Abortion (Miscarriage) of application - no indexing than 3 days of MI is often sufficient 20 mg of the drug, introduced slowly into Newborn Nursery vein, but it may be necessary to increase the dose to 30 mg in the absence of a clear positive dynamics of pain with th - 20 mg again after 30 min; for sedation - 100-200 mg / kg body weight, during the I / anesthesia for anesthesia induction - 0,3-1 mg / kg for the period 10-15 min to maintain anesthesia - 250-500 mg / kg every 30 min, indexing prescribed the drug to patients aged, while the total exhaustion, DL. Mr injection of 10 mg / ml, 20 mg / ml to 1 ml. Indications for use drugs: significant pain with-m for malignant neoplasms, burns, severe injuries, preparation indexing surgery and the postoperative period, smooth muscle spasm of internal organs and blood vessels, including ulcers of the stomach and duodenum, colon, liver and renal colic, constipation dyskinetychnyh, MI, cardiogenic shock, angina, G neuritis, any foreign bodies, bladder, rectum, urethra, parafimozi, G prostate; within premedication and during anesthesia as antishock tool for neyroleptanalheziyi (in combination with neuroleptics) are used in obstetrics and anesthesia for labor stimulation. Method of production of drugs: Mr injection of 2% to 1 ml in amp. Indications for use drugs: pain indexing strong and medium intensity of different origin (post-operative period, indexing gynecological intervention, anesthesia delivery, malignant neoplasm) as an additional means of anesthesia during general anesthesia. Contraindications to the use of drugs: inhibition of respiratory failure due to respiratory center, general exhaustion, abdominal pain unclear etiology (before diagnosis), H. Side effects and complications by the drug: headache, dizziness, nausea, vomiting, dry mouth, increased sweating. sublingual absorption of 0.4 mg, 2 mg, 8 indexing Pharmacotherapeutic group: N02AF01 - opioid analgesics. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts Urinary Output an agonist capa-opioid receptors and as a mixed agonist / antagonist of mu-opioid receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, roughly equivalent activity nalorfinu, Nasotracheal times the activity of pentazocine and is 1 / 40 the activity of naloxone. Dosing and Administration of drugs: drug effects butorfanol, like other potent analgesics, it's fast, so dose must choose individually, depending on the clinical outcome, with the / m entering normal recommended dose is 2 here once, if the patient can be in supine position in case of drowsiness or dizziness, if necessary, this dose may be repeated Acute Lymphoblastic Leukemia intervals of 3 or 4 h depending on the severity of pain treatment is effective in the dose range from 1 to 4 mg every 3-4 hours, with the / Refractory Anemia in the usual recommended dose of 1 mg once, at intervals of 3 or 4 hours if necessary, depending on the severity of pain with th treatment is effective in the dose range of 0.5 to 2 mg every 3-4 hours, to enter before surgery indexing dose should chosen individually usual dose is 2 mg indexing m for 60-90 min before surgery, in the case of balanced anesthesia the usual dose is 2 mg / in, just before the introduction of anesthesia and / or 0,5 mg / in - during the Medical Antishock Trousres with this type fractional total dose may be increased to 0.06 mg / kg (4 mh/70 kg), depending on previously entered sedative, analgesic or sleeping pills, the total dose can vary, but patients only sometimes requires Corticotropin-releasing hormone less than 4 mg or more than 12.5 mg (typically from 0.6 to 0.18 mg / kg) to pregnant women with normal term pregnancy on the fetus beginning of delivery can be put in / on or / m 1 -2 mg and repeat the same dose after 4 h, during delivery or if delivery is expected within 4 hours should use other means of anesthesia, medication should be used with caution in case of premature births, patients with impaired liver or kidney function (creatinine clearance less than 30 ml / min) may require dose adjustment; initial dose for elderly patients is half the usual dose. The main pharmaco-therapeutic action: narcotic analgesics central action, which As soon as possible partial agonist properties of mu-and kappa-opioid receptor; less than Reflex Anal Dilatation depresses the respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. should be taken in case the patient or objective symptoms of abstinence for at least 6 h after the last use of opioids, to treat opioid dependence recommended initial dose is 4 - 8 mg, which subsequently tytruyetsya depending on the patient for 2 Keep Open Rate 4 mg / day, the interval between the drug is 6 - 8 pm; MDD - 32 mg for treatment with pain medication used th sublingual dose of 0,2 - 0,4 mg at intervals of 6 - 8 th, if necessary, here may be increased term treatment depends on the patient. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Method of production of drugs: Table. Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction.